CytoMed Therapeutics Limited's total assets for Q4 2024 were $7.38M, a decrease of -8.32% from the previous quarter. GDTC total liabilities were $750.59K for the fiscal quarter, a 35.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.